Cover Image

Topical steroid withdrawal treated with ruxolitinib cream

Saved in:

Bibliographic Details
Main Authors:	Moira Shea, BS (Author), Erin Grinich, MD (Author), Eric Simpson, MD, MCR (Author)
Format:	Book
Published:	Elsevier, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream
by: Shannon Nugent, BS, et al.
Published: (2022)

Treatment of cutaneous lupus with topical ruxolitinib cream
by: Jonathan J. Park, PhD, et al.
Published: (2022)

Recalcitrant Hailey-Hailey disease successfully treated with topical ruxolitinib cream and dupilumab
by: Juna Khang, BA, et al.
Published: (2023)

Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream
by: Sophia S. Tran, BS, et al.
Published: (2024)

Ruxolitinib cream for the treatment of granuloma annulare
by: Austin J. Piontkowski, BS, et al.
Published: (2024)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
by: Jeffrey S. Smith, MD, PhD, et al.
Published: (2023)

Recalcitrant lichen planus pigmentosus treated with topical ruxolitinib
by: Hannah L. Cornman, BS, et al.
Published: (2023)

The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
by: Deesha Desai, BS, et al.
Published: (2024)

Efficacy of topical ruxolitinib for cutaneous dermatomyositis
by: Aviya Lanis, MD, et al.
Published: (2024)

Topical corticosteroid withdrawal in a pediatric patient
by: Julie Dhossche, MD, et al.
Published: (2017)

Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin
by: Donglin Zhang, BA, et al.
Published: (2023)

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis
by: Eleanor Pope, BA, et al.
Published: (2022)

Topical ruxolitinib for the treatment of granuloma faciale
by: Alan Wong, DO, et al.
Published: (2023)

Topical Steroid Withdrawal: A Case Series of 10 Children
by: Belinda Sheary
Published: (2019)

Abuse of topical steroid as cosmetic cream: A social background of steroid dermatitis
by: Rathi Sanjay
Published: (2006)

Tattoo pruritus successfully treated with ruxolitinib: A case series
by: Julianna Shin, BS, et al.
Published: (2024)

Porokeratoma treated with topical 5% 5-fluorouracil cream
by: Steve S. Li, BA, et al.
Published: (2021)

Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
by: Paul Smith, et al.
Published: (2021)

Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History
by: Andrew Blauvelt, et al.
Published: (2024)

Letter in response to the case report "Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis"
by: Meron Teklu, MD, et al.
Published: (2023)

Delayed granulomatous eruption of the nose associated with ruxolitinib
by: Margaret Brown, MD, et al.
Published: (2020)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
by: Sean J. Igelman, BS, et al.
Published: (2020)

Designing a Topical Nanoliposomal Formulation of Ruxolitinib Phosphate
by: Atefeh Naeimifar, et al.
Published: (2023)

'Magic Cream'-All treats, no tricks. The use of topical steroids for the treatment of hypergranulation tissue in burn wounds: A retrospective review
by: Lam Hui Yuan, et al.
Published: (2022)

Steroid withdrawal protocols in Renal Transplantation
by: Anindya Banerjee, et al.
Published: (2018)

Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
by: Lawrence F. Eichenfield, et al.
Published: (2024)

Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
by: Eric L. Simpson, et al.
Published: (2024)

Development of sebaceous carcinoma in a patient on ruxolitinib therapy
by: Noreen Mohsin, BS, et al.
Published: (2022)

Topical dermal steroid-induced retinopathy
by: Taylor Hilton, MS, et al.
Published: (2020)

Management of pediatric steroid-refractory graft versus host disease: Challenges and outcome with ruxolitinib and etanercept
by: Sanjana Sarangarajan, et al.
Published: (2024)

Superficial basal cell carcinoma treated with curettage followed by topical imiquimod cream: A retrospective study
by: Andrew L. Ondo, MD, et al.
Published: (2024)

Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years
by: John E. Harris, et al.
Published: (2024)

Report of novel treatment of segmental vitiligo using combined microneedling and topical ruxolitinib
by: Rama Abdin, et al.
Published: (2024)

Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream
by: Michael D. Howell, et al.
Published: (2023)

Topical Imiquimod 5% Cream Versus Salicylic acid 30% Cream in Treating Common Warts: A comparative study
by: Dilpak Muhammed-Ameen, et al.
Published: (2022)

Treatment of angiokeratomas of Fordyce with topical rapamycin 0.25% cream
by: Katheryn A. Bell, BA, et al.
Published: (2021)

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
by: Wei C, et al.
Published: (2021)

Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with Ruxolitinib
by: Vera Stoeva, et al.
Published: (2023)

Herpes zoster infection after topical steroid use in the setting of tumid lupus erythematosus
by: Rachel Powell, MD, et al.
Published: (2018)

Successful treatment of alopecia totalis with ruxolitinib in a preadolescent patient
by: Danielle M. Peterson, MD, et al.
Published: (2020)